DD

Darshana Devi

Active Director Director DIN 07564546
DIN 07564546 First appointment Jul 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value •••• Premium profile

About Darshana Devi

Data last updated:

Darshana Devi is a Director at Axodin Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Axodin Pharmaceuticals Private Limited reported revenue of ₹4.72 Cr (FY 2025).

DIN 07564546
Primary Designation Director
Industry Pharma
First Appointment 25 Jul 2016
Oldest Company Age 10 yrs
Largest company Axodin Pharmaceuticals Private Limited · ₹4.72 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20162016₹4.72 Cr (FY 2025)Active

Board colleagues of Darshana Devi

NameDINCompanyDesignation
Rahul Saini07073374Axodin Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Axodin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Darshana Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Darshana Devi

Darshana Devi currently holds 1 directorship: Axodin Pharmaceuticals Private Limited (Director, since 25 Jul 2016, revenue ₹4.72 Cr (FY 2025)).

Darshana Devi was first appointed on 25 Jul 2016 as Director at Axodin Pharmaceuticals Private Limited.

The current boards of Darshana Devi's companies include Rahul Saini (Axodin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available